StockData
Mineralys Therapeutics, Inc. logo

Mineralys Therapeutics, Inc. (MLYS) stock

MLYSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$13.78−0.70 (-4.83%)

Close on Nov 18, 2026Market cap $1.22BP/E –Yield –

Mineralys Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Mineralys Therapeutics's market cap was $1.43B on Nov 11, 2026, against $3.41B a year earlier. Over the last 4 years it ranged from $86.34M to $3.41B, with a median of $665.13M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.43B-50.2%
2025Dec 31, 2025$2.87B+367.9%
2024Dec 31, 2024$612.50M+73.3%
2023Dec 29, 2023$353.50M–

More Mineralys Therapeutics figures

See a number that looks wrong?